Menard Financial Group’s Colgate-Palmolive CL Stock Holding History

Menard Financial Group’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,123	Closed	-$102K	–	133
2024 Q4	$102K	Buy	+1,123	New	+$107K	0.06%	137

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Menard Financial Group's CL Position: Q1 2025 in Review

Menard Financial Group sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 1,123 shares — an estimated $102K sold.

Menard Financial Group first reported a position in CL in Q4 2024 and held it in 1 quarter. The position peaked at $102K in Q4 2024. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

Menard Financial Group reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
Menard Financial Group sold 1,123 Colgate-Palmolive shares in Q1 2025, an estimated $102K.
Menard Financial Group first reported a position in Colgate-Palmolive in Q4 2024 and held it in 1 quarter.
Menard Financial Group's Colgate-Palmolive position peaked at $102K in Q4 2024.
1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Menard Financial Group's 13F filing for Q1 2025, filed 8 May 2025.